Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2023 1
2024 2
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jonathan karnon (226 results)?
Real-World Data on Osimertinib-Associated Cardiac Toxicity.
Agbarya A, Raphael A, Gantz Sorotsky H, Rottenberg Y, Šebek V, Radonjic D, Yakobson A, Arnon J, Shalata W. Agbarya A, et al. Among authors: arnon j. J Clin Med. 2025 Mar 5;14(5):1754. doi: 10.3390/jcm14051754. J Clin Med. 2025. PMID: 40095892 Free PMC article.
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.
Arnon J, Dinstag G, Tirosh O, Gugel L, Kinar Y, Gottlieb T, Elia A, Rottenberg Y, Nechushtan H, Tabi M, Blumenfeld P, Pikarsky E, Beker T, Aharonov R, Popovtzer A. Arnon J, et al. J Immunother Cancer. 2025 Jan 11;13(1):e010132. doi: 10.1136/jitc-2024-010132. J Immunother Cancer. 2025. PMID: 39800380 Free PMC article.
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.
Arnon J, Tabi M, Rottenberg Y, Zick A, Blumenfeld P, Hamburger T, Pikarsky E, Avraham E, Levine L, Popovtzer A, Yablonski-Peretz T, Kadouri L, Nechushtan H. Arnon J, et al. Cancers (Basel). 2023 Sep 26;15(19):4733. doi: 10.3390/cancers15194733. Cancers (Basel). 2023. PMID: 37835426 Free PMC article.
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy.
Tsur E, Blumenfeld P, Rottenberg Y, Nechushtan H, Arnon J, Wald O, Izhar U, Pfeffer R, Krakow A, Wygoda M, Popovtzer A, Michaeli TF. Tsur E, et al. Among authors: arnon j. Transl Lung Cancer Res. 2024 Mar 29;13(3):465-474. doi: 10.21037/tlcr-23-802. Epub 2024 Mar 22. Transl Lung Cancer Res. 2024. PMID: 38601442 Free PMC article.
Clinical and genetic characteristics of carriers of the TP53 c.541C > T, p.Arg181Cys pathogenic variant causing hereditary cancer in patients of Arab-Muslim descent.
Arnon J, Zick A, Maoz M, Salaymeh N, Gugenheim A, Marouani M, Mor E, Hamburger T, Saadi N, Elia A, Ganz G, Fahham D, Meirovitz A, Kadouri L, Meiner V, Yablonski-Peretz T, Shkedi-Rafid S. Arnon J, et al. Fam Cancer. 2024 Nov;23(4):531-542. doi: 10.1007/s10689-024-00391-2. Epub 2024 May 14. Fam Cancer. 2024. PMID: 38743206 Free PMC article.
Non-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report.
Hadhud M, Arnon J, Hershko-Moshe A, Hollander A, Hurvitz-Lehmann N, Potruch A, Azmanov H, Kuint R, Hiller N, Picard E, Sebbag-Sznajder N, Leebhoff S, Wilschanski M, Grunewald M, Birimberg-Schwartz L, Cohen-Cymberknoh M. Hadhud M, et al. Among authors: arnon j. Respir Med Case Rep. 2025 Jan 25;53:102171. doi: 10.1016/j.rmcr.2025.102171. eCollection 2025. Respir Med Case Rep. 2025. PMID: 39980610 Free PMC article.
11 results